Roger LeBlanc
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 21
- HIV Research and Treatment 21
-
- HIV/AIDS Research and Interventions 11
- HIV/AIDS drug development and treatment 8
- Co-authors
- Jean‐Pierre Routy (23 shared papers)Danielle Rouleau (16 shared papers)Cécile Tremblay (17 shared papers)Réjean Thomas (14 shared papers)Mark A. Wainberg (5 shared papers)Bluma Brenner (3 shared papers)Julie Bruneau (6 shared papers)Jean‐Guy Baril (3 shared papers)
- Journals
- The Journal of Infectious Diseases (4 papers)AIDS (3 papers)PLoS ONE (2 papers)HIV Clinical Trials (2 papers)Viruses (2 papers)
- Partner nations
- CanadaUnited StatesFrance
In The Last Decade
Roger LeBlanc
32 papers receiving 1.3k citations
Roger LeBlanc's Hit Papers
Peers
Comparison fields: 5 of 92
- Virology 686
- Infectious Diseases 670
- Emergency Medicine 107
- Biological Psychiatry 24
- Immunology 199
Countries citing papers authored by Roger LeBlanc
This map shows the geographic impact of Roger LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger LeBlanc more than expected).
Fields of papers citing papers by Roger LeBlanc
This network shows the impact of papers produced by Roger LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger LeBlanc. The network helps show where Roger LeBlanc may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger LeBlanc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection Hit paper breakdown → | 2007 | 500 |
| 2 | 2000 | 180 | |
| 3 | 2015 | 106 | |
| 4 | 2020 | 68 | |
| 5 | 2015 | 54 | |
| 6 | 2005 | 51 | |
| 7 | 2019 | 43 | |
| 8 | 2003 | 41 | |
| 9 | 2016 | 30 | |
| 10 | 2002 | 26 | |
| 11 | 2019 | 26 | |
| 12 | 2000 | 23 | |
| 13 | 2018 | 19 | |
| 14 | 2017 | 18 | |
| 15 | 2009 | 17 | |
| 16 | 2000 | 16 | |
| 17 | 2021 | 13 | |
| 18 | 2005 | 11 | |
| 19 | 2005 | 10 | |
| 20 | 2019 | 8 |
About Roger LeBlanc
Roger LeBlanc is a scholar working on Virology, Infectious Diseases, Immunology, Epidemiology and Hematology, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), HIV/AIDS Research and Interventions (11 papers), HIV/AIDS drug development and treatment (8 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (4 papers), HIV, Drug Use, Sexual Risk (3 papers), HIV-related health complications and treatments (2 papers) and Blood groups and transfusion (2 papers). The work is most often cited by research in Virology (686 citations), Infectious Diseases (670 citations), Emergency Medicine (107 citations), Biological Psychiatry (24 citations) and Immunology (199 citations). Roger LeBlanc has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Jean‐Pierre Routy, Danielle Rouleau, Cécile Tremblay, Réjean Thomas, Mark A. Wainberg, Bluma Brenner, Julie Bruneau, Jean‐Guy Baril, Michel Roger and Daniela Moïsi. Their work appears in journals such as The Journal of Infectious Diseases, AIDS, PLoS ONE, HIV Clinical Trials and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.